Allurion Technologies Inc. (NYSE:ALUR) CEO Shantanu Gaur Acquires 8,000 Shares

Allurion Technologies Inc. (NYSE:ALUR) CEO Shantanu Gaur acquired 8,000 shares of the business’s stock in a transaction dated Friday, March 28th. The stock was purchased at an average cost of $3.35 per share, for a total transaction of $26,800.00. Following the transaction, the chief executive officer now owns 8,000 shares in the company, valued at approximately $26,800. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Allurion Technologies Stock Performance

ALUR stock traded up $0.12 during trading on Tuesday, reaching $3.33. The company had a trading volume of 130,364 shares, compared to its average volume of 714,923. The company has a market cap of $15.94 million, a price-to-earnings ratio of -0.28 and a beta of -0.59. Allurion Technologies Inc. has a twelve month low of $2.15 and a twelve month high of $98.75. The firm has a 50-day simple moving average of $4.02 and a 200-day simple moving average of $9.57.

Allurion Technologies (NYSE:ALUR) last posted its quarterly earnings data on Wednesday, March 26th. The company reported ($7.00) EPS for the quarter, missing the consensus estimate of ($5.00) by ($2.00). The firm had revenue of $5.59 million for the quarter, compared to analyst estimates of $5.60 million. Sell-side analysts expect that Allurion Technologies Inc. will post -9.96 earnings per share for the current year.

Institutional Trading of Allurion Technologies

An institutional investor recently raised its position in Allurion Technologies stock. Geode Capital Management LLC increased its position in shares of Allurion Technologies Inc. (NYSE:ALUR) by 40.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 516,330 shares of the company’s stock after purchasing an additional 149,484 shares during the quarter. Geode Capital Management LLC owned 0.80% of Allurion Technologies worth $317,000 as of its most recent SEC filing. Institutional investors own 21.39% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on ALUR shares. Roth Mkm reaffirmed a “buy” rating and issued a $16.00 price target on shares of Allurion Technologies in a report on Friday, March 21st. Chardan Capital reissued a “neutral” rating and issued a $2.50 price objective on shares of Allurion Technologies in a research report on Thursday, March 27th.

About Allurion Technologies

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.